Suppr超能文献

新型蛋白酶抑制剂调控疟原虫半胱氨酸蛋白酶活性的结构基础。

Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.

机构信息

Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Lübeck, 23538 Lübeck, Germany.

出版信息

Structure. 2011 Jul 13;19(7):919-29. doi: 10.1016/j.str.2011.03.025.

Abstract

Plasmodium cysteine proteases are essential for host-cell invasion and egress, hemoglobin degradation, and intracellular development of the parasite. The temporal, site-specific regulation of cysteine-protease activity is a prerequisite for survival and propagation of Plasmodium. Recently, a new family of inhibitors of cysteine proteases (ICPs) with homologs in at least eight Plasmodium species has been identified. Here, we report the 2.6 Å X-ray crystal structure of the C-terminal, inhibitory domain of ICP from P. berghei (PbICP-C) in a 1:1 complex with falcipain-2, an important hemoglobinase of Plasmodium. The structure establishes Plasmodium ICP as a member of the I42 class of chagasin-like protease inhibitors but with large insertions and differences in the binding mode relative to other family members. Furthermore, the PbICP-C structure explains why host-cell cathepsin B-like proteases and, most likely, also the protease-like domain of Plasmodium SERA5 (serine-repeat antigen 5) are no targets for ICP.

摘要

疟原虫半胱氨酸蛋白酶对于宿主细胞入侵和逸出、血红蛋白降解以及寄生虫的细胞内发育至关重要。半胱氨酸蛋白酶活性的时空特异性调节是疟原虫存活和繁殖的前提。最近,已经鉴定出至少 8 种疟原虫种属中具有同源物的新型半胱氨酸蛋白酶抑制剂(ICPs)家族。在这里,我们报告了来自 P. berghei 的 ICP 的 C 末端抑制结构域(PbICP-C)与裂殖体蛋白酶 2(Plasmodium 的一种重要血红蛋白酶)以 1:1 复合物的 2.6Å X 射线晶体结构。该结构将疟原虫 ICP 确定为 I42 类 chagasin 样蛋白酶抑制剂的成员,但与其他家族成员相比,存在较大的插入和结合模式差异。此外,PbICP-C 结构解释了为什么宿主细胞组织蛋白酶 B 样蛋白酶,并且很可能还有 Plasmodium SERA5(丝氨酸重复抗原 5)的蛋白酶样结构域不是 ICP 的靶标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验